Author

Colin Osterloh

University of Lübeck

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:host-pathogen & immune response· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Anja LuxiD· 3 shared Ann‐Kathrin Schneider· 3 shared Frank PeterseniD· 3 shared Gestur VidarssoniD· 3 shared Katja BieberiD· 3 shared Mareile SchlotfeldtiD· 3 shared Nancy ErnstiD· 3 shared Remco VisseriD· 3 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

Anja LuxORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

An unbiased map of FcγR signaling in neutrophils reveals druggable nodes in immune complex-mediated autoimmune disease

Mareile Schlotfeldt, Colin Osterloh, Anika Kasprick, Carla Zünkeler, Mikko Armbrust, Georg Kaiser, Katharina Schulze Dieckhoff, Thorge Mester, Pia Stüssel, Nancy Ernst, Ann‐Kathrin Schneider, Leonie Voss, Adrian Pablo Mansini, Seyed Mohammad Vahabi, Yulu F. Wang, , Katja Bieber

The paper identifies BTK as a therapeutic target in antibody-mediated autoimmune diseases by mapping FcγR signaling in neutrophils using kinase inhibitors and disease models.

bioRxiv · Oct 19, 2026 · PreprintImmunology

CDK7, CDK9, or CDK11 Inhibition Reduces Neutrophil-Driven Inflammation and Tissue Damage in Experimental Autoimmune Models

Mareile Schlotfeldt, Leonie Voss, Adrian Pablo Mansini, Daniel Mehlberg, Sophia Johannisson, Michael Radziewitz, Ann‐Kathrin Schneider, Seyed Mohammad Vahabi, Yulu Wang, Haley Gainer, Jing Li, Colin Osterloh, Nancy Ernst, Remco Visser, Gestur Vidarsson, , Katja Bieber

Cell Communication and Signaling · Sep 30, 2026Peer-reviewedImmunology

ERK5 is required for neutrophil-mediated ROS release and essential in epidermolysis bullosa acquisita

Sören Dräger, Mareile Schlotfeldt, Leonie Caroline Voß, Sophia Johannisson, Michael Radziewitz, Colin Osterloh, Natalie Gross, Mayumi Kamaguchi, Ann‐Kathrin Schneider, Gestur Vidarsson, Remco Visser, Frank Petersen, Xinhua Yu, Andreas Recke, Nancy Ernst, , Katja Bieber

This study shows ERK5 inhibition reduces neutrophil ROS release and ameliorates EBA, suggesting ERK5 as a therapeutic target in ROS-driven autoimmune diseases.

bioRxiv · Nov 12, 2025 · PreprintImmunology